A Phase I, Single-Blinded, Randomized Study of Nebulized RNS60 in Combination With Budesonide in Adult Subjects With Mild to Moderate Asthma
Phase of Trial: Phase I
Latest Information Update: 20 May 2015
At a glance
- Drugs RNS 60 (Primary) ; Budesonide
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Revalesio
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Feb 2013 Planned End Date changed from 1 Mar 2013 to 1 May 2013 as reported by ClinicalTrials.gov.
- 19 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.